Adicet Bio, Inc. Increase (Decrease) in Deferred Liabilities
Adicet Bio, Inc. (ACET) reported Increase (Decrease) in Deferred Liabilities of $400.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredLiabilities · last filed 2021-11-10
- Adicet Bio, Inc. increase (decrease) in deferred liabilities for the quarter ending 2020-12-31 was $519.00K.
- Adicet Bio, Inc. increase (decrease) in deferred liabilities for the quarter ending 2020-09-30 was -$32.00K.
- Adicet Bio, Inc. increase (decrease) in deferred liabilities for the quarter ending 2019-12-31 was -$37.00K.
- Adicet Bio, Inc. increase (decrease) in deferred liabilities for fiscal 2020 was $400.00K.
- Adicet Bio, Inc. increase (decrease) in deferred liabilities for fiscal 2019 was -$148.00K.
- Adicet Bio, Inc. increase (decrease) in deferred liabilities for fiscal 2018 was -$132.00K.
| Period end | Increase (Decrease) in Deferred Liabilities 3 month | Increase (Decrease) in Deferred Liabilities 6 month | Increase (Decrease) in Deferred Liabilities 9 month | Increase (Decrease) in Deferred Liabilities 12 month |
|---|---|---|---|---|
| 2020-12-31 | $519.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $487.00K derived: sum of 2 quarters · filed 2021-11-10 | $400.00K 10-K · filed 2021-03-12 | |
| 2020-09-30 | -$32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$119.00K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | -$87.00K 10-Q · filed 2021-08-12 | |||
| 2019-12-31 | -$37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$148.00K 10-K · filed 2021-03-12 | ||
| 2019-09-30 | -$111.00K 10-Q · filed 2020-11-05 | |||
| 2018-12-31 | -$132.00K 10-K · filed 2021-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |